Categories AlphaGraphs, Earnings, Health Care

BMY Earnings: Everything you need to know about Bristol Myers’ Q4 results

Bristol Myers Squibb (NYSE: BMY) on Thursday announced results for the fourth quarter of 2022, reporting lower earnings and revenues.

Bristol Myers Squibb Q4 2022 earnings infographic

The pharma company reported revenues of $11.4 billion for the fourth quarter, down 5% from the same period a year ago. Net earnings attributable to the company were $2.02 billion, or $0.95 per share, compared to $2.37 billion, or $1.07 per share a year earlier. Adjusted earnings edged down by 1% to $1.82 per share.

“With a younger and more diversified portfolio, promising mid-to-late-stage registrational assets, and a deep early-stage pipeline, I am confident that the company is well-positioned for multiple waves of innovation that will support long-term growth,” said the company’s CEO Giovanni Caforio.

Prior Performance

  • Bristol-Myers-Squibb-Q3-2022-Earnings-Infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Key takeaways from Cintas’ (CTAS) third-quarter 2023 report

Cintas Corporation (NASDAQ: CTAS) has been growing its market share by diversifying into new areas and through acquisitions. The prudent business model, with a focus on recurring revenues, has helped

Here are a few points to keep in mind if you are considering Starbucks Corporation (SBUX)

Shares of Starbucks Corporation (NASDAQ: SBUX) stayed in green on Thursday. The stock has gained 10% over the past 12 months. The company delivered healthy results for its most recent

ANGO Earnings: AngioDynamics reports loss for Q3; revenue up 9%

AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported a wider loss for the third quarter when the medical device maker's revenues increased by 9%. The company also provided guidance for fiscal

Add Comment
Viewing Highlight